ASPI vs LEU
ASPI: An advanced materials company commercializing proprietary isotope enrichment technologies for nuclear medicine, semiconductors, and small modular reactors, combined with LNG and helium production through its Renergen subsidiary. LEU: Domestic uranium enrichment provider supplying low-enriched uranium (LEU) and high-assay low-enriched uranium (HALEU) to U.S. nuclear power plants and the Department of Energy.
Side-by-side fundamentals
| Metric | ASPI | LEU | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $4.08 | $174.28 | |
| Market cap as of 2026-07-23 | $514M | $3.4B | |
| P/E as of 2026-07-23 | n/a | 56.66 | |
| PEG as of 2026-07-23 | -0.01 | n/a | |
| Net margin as of 2026-07-23 | -644.4% | +13.4% | LEU higher |
| Gross margin as of 2026-07-23 | +17.6% | +25.7% | LEU higher |
| Operating margin as of 2026-07-23 | -285.4% | +6.7% | LEU higher |
| ROE as of 2026-07-23 | -117.2% | +10.7% | LEU higher |
| ROA as of 2026-07-23 | -47.9% | +2.9% | LEU higher |
| Debt / equity as of 2026-07-23 | 0.90 | 1.52 | ASPI lower |
| Revenue growth (YoY) as of 2026-07-23 | +511.2% | -4.0% | ASPI higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +15.2% | |
| Beta as of 2026-07-23 | 3.73 | 1.38 | |
| 1-year return as of 2026-07-22 close | -56.2% | -19.3% | LEU higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.